rs1557238665
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000052.7(ATP7A):c.4006-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000052.7 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease due to phosphoglycerate kinase 1 deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP7A | NM_000052.7 | c.4006-1G>A | splice_acceptor_variant, intron_variant | Intron 20 of 22 | ENST00000341514.11 | NP_000043.4 | ||
| ATP7A | NM_001282224.2 | c.3772-1G>A | splice_acceptor_variant, intron_variant | Intron 19 of 21 | NP_001269153.1 | |||
| ATP7A | NR_104109.2 | n.1179-1G>A | splice_acceptor_variant, intron_variant | Intron 7 of 9 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATP7A | ENST00000341514.11 | c.4006-1G>A | splice_acceptor_variant, intron_variant | Intron 20 of 22 | 1 | NM_000052.7 | ENSP00000345728.6 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 24
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
ATP7A-related disorder Pathogenic:1
The ATP7A c.4006-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant has been reported in an individual with Menkes syndrome (Table 1, Parad et al. 2020. PubMed ID: 32714836). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice acceptor site in ATP7A are expected to be pathogenic. This variant is interpreted as likely pathogenic.
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 Pathogenic:1
In summary, donor and acceptor splice site variants are typically loss-of-function (PMID: 16199547), and loss-of-function variants in ATP7A are known to be pathogenic (PMID: 20652413, 11241493). However, without additional functional and/or genetic data, this variant has been classified as Likely Pathogenic. This variant has not been reported in the literature in individuals with a ATP7A-related disease. This sequence change affects an acceptor splice site in intron 20 of the ATP7A gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at